2012
DOI: 10.1186/1471-2172-13-50
|View full text |Cite
|
Sign up to set email alerts
|

Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction

Abstract: BackgroundSevere acute respiratory syndrome (SARS) is an emerging infectious disease caused by the novel coronavirus SARS-CoV. The T cell epitopes of the SARS CoV spike protein are well known, but no systematic evaluation of the functional and structural roles of each residue has been reported for these antigenic epitopes. Analysis of the functional importance of side-chains by mutational study may exaggerate the effect by imposing a structural disturbance or an unusual steric, electrostatic or hydrophobic int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 37 publications
(38 reference statements)
0
6
0
Order By: Relevance
“…By contrast, a peptide of the homologous region on the SARS-CoV-2 S protein (CYGVSPTKL; aa 379–387) was not recognized by CTLs in our study. The replacement of residue A371 by K or D in this epitope of SARS-CoV led to decreased recognition of the peptide by CTLs, suggesting that residue A371 is critical for epitope recognition by CTLs [16] . To determine the minimal epitope(s) required, we synthesized five truncated peptides of peptide #10 (shown in Table 1 ) and used them to stimulate CTLs from the immunized mice in vitro.…”
Section: Resultsmentioning
confidence: 99%
“…By contrast, a peptide of the homologous region on the SARS-CoV-2 S protein (CYGVSPTKL; aa 379–387) was not recognized by CTLs in our study. The replacement of residue A371 by K or D in this epitope of SARS-CoV led to decreased recognition of the peptide by CTLs, suggesting that residue A371 is critical for epitope recognition by CTLs [16] . To determine the minimal epitope(s) required, we synthesized five truncated peptides of peptide #10 (shown in Table 1 ) and used them to stimulate CTLs from the immunized mice in vitro.…”
Section: Resultsmentioning
confidence: 99%
“…Collectively, these interactions indicate a potentially successful presentation of the epitopes by MHC class I molecules, thereby activating CTLs and generating immune responses. We compared the epitopes obtained in our study with epitopes predicted in the spike protein of MERS‐CoV and SARS‐CoV 22,23 . We found one overlapping CTL epitope between MERS‐CoV and 2019‐nCoV with one gap and one mismatch (YLQPRTFLL/YKLQPLTFLL), and no comparable epitopes with SARS‐CoV.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, a safe vaccine, which is dependent on the investigation of specific epitopes derived from SARS‐CoV‐2 structural proteins and the availability of sequence data, is the most effective intervention for suppressing SARS‐CoV‐2 infection. However, identified epitopes are unstable due to difficulties in epitope detection in glycoproteins, error‐prone SARS‐CoV‐2 replication, and the continuous evolution and the mutations of SARS‐CoV‐2 127 . Thus, epitopes should be further screened according to the conservative filtering principle, consequently producing a more accurate epitope set.…”
Section: Future Perspectivesmentioning
confidence: 99%